JP6751386B2 - Drug delivery device and system with motion detector for recording and tracking user activity - Google Patents

Drug delivery device and system with motion detector for recording and tracking user activity Download PDF

Info

Publication number
JP6751386B2
JP6751386B2 JP2017509755A JP2017509755A JP6751386B2 JP 6751386 B2 JP6751386 B2 JP 6751386B2 JP 2017509755 A JP2017509755 A JP 2017509755A JP 2017509755 A JP2017509755 A JP 2017509755A JP 6751386 B2 JP6751386 B2 JP 6751386B2
Authority
JP
Japan
Prior art keywords
drug delivery
delivery device
drug
data
logging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017509755A
Other languages
Japanese (ja)
Other versions
JP2017525473A (en
Inventor
バウス，マルクス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHL Medical AG
Original Assignee
SHL Medical AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHL Medical AG filed Critical SHL Medical AG
Publication of JP2017525473A publication Critical patent/JP2017525473A/en
Application granted granted Critical
Publication of JP6751386B2 publication Critical patent/JP6751386B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
    • A61M5/31566—Means improving security or handling thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3202—Devices for protection of the needle before use, e.g. caps
    • G—PHYSICS
    • G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
    • G09B19/00—Teaching not covered by other main groups of this subclass
    • G—PHYSICS
    • G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
    • G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
    • G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
    • G09B23/285—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine for injections, endoscopy, bronchoscopy, sigmoidscopy, insertion of contraceptive devices or enemas
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14288—Infusion or injection simulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/18—General characteristics of the apparatus with alarm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3317—Electromagnetic, inductive or dielectric measuring means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/332—Force measuring means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3561—Range local, e.g. within room or hospital
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/82—Internal energy supply devices
    • A61M2205/8206—Internal energy supply devices battery-operated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/63—Motion, e.g. physical activity
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof

Description

技術分野
本発明は、薬剤送達のための装置およびシステムに関する。 TECHNICAL FIELD The present invention relates to devices and systems for drug delivery.

背景
公開番号ＵＳ２０１３／０２３６８７２のＵＳ特許出願は、実際の自動的な注入装置の操作をシミュレーションしおよび／または模倣するために、再使用可能な自動的な注入訓練装置、およびその構成要素を説明する。 BACKGROUND The US patent application with publication number US2013/0236872 describes a reusable automatic infusion training device and its components for simulating and/or mimicking the operation of an actual automatic infusion device. ..

ＵＫ特許出願番号ＧＢ２４９０７２３は人的要因研究に使用するための注射器を説明する。 UK Patent Application No. GB2490723 describes a syringe for use in human factor studies.

ＵＳ特許番号ＵＳ８，５５６，８６５は使い捨ての薬剤送達ペンまたは再使用可能な薬剤送達ペンに取り付けられるよう構成されたモジュールを説明し、モジュールは選択された投与量、その選択された投与量の注入、注入の継続時間、注入の時間、インスリン混合物を完全に混合するためにペンが整えられるか振られるかどうかを決定し、インスリン投与量および注入に関する情報をデータ管理ユニットに送信し、不正確な使用または針の再使用についてのリマインド、エラー、警告またはメッセージを提供し、搭載された薬の使い切りに関してペンに残ったあるいはペンの使用中の薬の量を追跡し、あるいはペンおよびモジュールの誤った位置づけ時に可聴の警告を提供してもよい。 US Patent No. US8,556,865 describes a module configured to be attached to a disposable drug delivery pen or a reusable drug delivery pen, the module comprising a selected dose, infusion of the selected dose. Determine the duration of the infusion, the time of infusion, whether the pen is trimmed or shaken to thoroughly mix the insulin mixture, send information about the insulin dose and infusion to the data management unit, Provides reminders, errors, warnings or messages about use or needle reuse, keeps track of the amount of drug left in the pen or in use with the pen for exhausted drug loading, or incorrect pen and module An audible warning may be provided during positioning.

概要
本発明の実施形態の目的は薬剤送達の促進である。 Overview The purpose of embodiments of the present invention is to facilitate drug delivery.

本発明の実施形態のさらなる目的は使用者がどのように装置を操作するかの分析を促進しこれにより薬剤送達装置の正確な使用のための改善された訓練を提供することである。 A further object of embodiments of the present invention is to facilitate analysis of how the user operates the device, thereby providing improved training for the correct use of the drug delivery device.

第１の局面によれば、センサ装置およびロギング装置を備える薬剤送達装置が示される。センサ装置は薬剤送達装置の動きを検知するよう構成される。ロギング装置は薬剤送達装置の使用者の行動を追跡するよう構成され、その使用者の行動はセンサ装置によって検知された動きに基づく。薬剤送達装置の動きを追跡することにより、研究、訓練または遵守のための使用者の行動の追跡が改善され、それは薬剤送達を促進する。 According to a first aspect, a drug delivery device comprising a sensor device and a logging device is shown. The sensor device is configured to detect movement of the drug delivery device. The logging device is configured to track the behavior of the user of the drug delivery device, the behavior of the user being based on movements detected by the sensor device. Tracking the movement of the drug delivery device improves tracking of the user's behavior for research, training or compliance, which facilitates drug delivery.

センサ装置は概ね動きを検知可能なあらゆる種類のセンサを意味する。好ましくは、センサ装置は１または複数の以下のセンサ：磁力計、ジャイロスコープおよび／または加速度計を備えてもよく、高度に正確な動きの追跡が改善される。 The sensor device generally means any kind of sensor capable of detecting movement. Preferably, the sensor device may comprise one or more of the following sensors: magnetometer, gyroscope and/or accelerometer to improve highly accurate motion tracking.

薬剤送達装置はロギング装置からのデータを保管するよう構成された記憶装置をさらに備えてもよく、その使用者のための追跡が促進される。記憶装置は不揮発性のメモリを備えてもよい。 The drug delivery device may further comprise a storage device configured to store data from the logging device, facilitating tracking for its user. The storage device may include a non-volatile memory.

薬剤送達装置はロギング装置からのデータを薬剤送達装置の外部のコンピュータに送信するよう構成された通信装置をさらに備えてもよい。 The drug delivery device may further comprise a communication device configured to send data from the logging device to a computer external to the drug delivery device.

実施形態によれば、通信装置は無線または有線でロギング装置からのデータをリアルタイム送信するよう構成されてもよく、追跡のリアルタイム可視化が達成される。 According to embodiments, the communication device may be configured to transmit data from the logging device in real time, wirelessly or wired, to achieve real time visualization of the tracking.

他の実施形態によれば、通信装置は記憶装置内に保管されたデータを無線または有線で送信するよう構成される。 According to another embodiment, the communication device is configured to wirelessly or wiredly transmit the data stored in the storage device.

ロギング装置は薬剤送達装置が輸送ボックスから取り外された際に使用者の行動追跡を開始するよう構成されてもよく、これによりその使用者のための追跡が促進される。 The logging device may be configured to initiate behavioral tracking of the user when the drug delivery device is removed from the shipping box, which facilitates tracking for that user.

さらなる実施形態によれば、ロギング装置は薬剤送達装置の保護キャップが取り外された際に使用者の行動追跡を開始するよう構成されてもよく、これによりその使用者のための追跡が促進される。 According to a further embodiment, the logging device may be configured to initiate behavioral tracking of the user when the protective cap of the drug delivery device is removed, which facilitates tracking for that user. ..

薬剤送達装置は薬剤の注入のための実際の送達装置でもよく、人的要因の研究または訓練のためのモックアップデモ装置であってもよい。 The drug delivery device may be an actual delivery device for injection of a drug or a mockup demo device for human factor research or training.

第２の局面によれば、薬剤送達装置の使用者の行動追跡の方法が提供される。方法は、薬剤送達装置の動きを検知するステップ；および検知された動きに基づいて薬剤送達装置の使用者の行動を追跡するステップとを備える。 According to a second aspect, a method of tracking the behavior of a user of a drug delivery device is provided. The method comprises detecting movement of the drug delivery device; and tracking the behavior of the user of the drug delivery device based on the detected movement.

第３の局面によれば、薬剤送達システムが提供される。薬剤送達システムは薬剤送達装置、ディスプレイ装置を有する薬剤送達装置の外部のコンピュータ装置を備える。薬剤送達装置はセンサ装置、ロギング装置および通信装置を備える。センサ装置は薬剤送達装置の動きを検知するよう構成される。ロギング装置は薬剤送達装置の使用者の行動を追跡するよう構成され、その使用者の行動はセンサ装置によって検知された動きに基づく。通信装置はロギング装置からのリアルタイムデータを薬剤送達装置外部のコンピュータ装置または後の分析のための遠隔地に無線および／または有線で送信するよう構成される。通信装置もまたロギング憶装置内に保管されたデータをロギング装置から薬剤送達装置外部のコンピュータ装置または後の分析のために遠隔地に無線および／または有線で送信するよう構成される。 According to a third aspect, a drug delivery system is provided. The drug delivery system comprises a drug delivery device, a computer device external to the drug delivery device having a display device. The drug delivery device comprises a sensor device, a logging device and a communication device. The sensor device is configured to detect movement of the drug delivery device. The logging device is configured to track the behavior of the user of the drug delivery device, the behavior of the user being based on movements detected by the sensor device. The communication device is configured to wirelessly and/or wiredly transmit real-time data from the logging device to a computer device external to the drug delivery device or to a remote location for later analysis. The communication device is also configured to wirelessly and/or wiredly transmit the data stored in the logging device from the logging device to a computer device external to the drug delivery device or to a remote location for later analysis.

概ね、請求項内で使用されるすべての用語は、ここで明確にそれ以外に定義されない限り、技術分野における通常の意味によって解釈されるべきである。「要素、装置、構成要素、手段、ステップなど」のすべての意味は、ここで明確にそれ以外に定義されない限り、要素、装置、構成要素、手段、ステップなどの少なくとも１つの例を意味するものとしてオープンに解釈されるべきである。ここで開示されたあらゆる方法のステップは、明確に述べられない限り、開示された正確な順番で実行されなければならないわけではない。 In general, all terms used in the claims are to be interpreted according to their ordinary meaning in the technical field, unless explicitly defined otherwise herein. All meanings of "element, device, component, means, step, etc." mean at least one example of element, device, component, means, step, etc., unless expressly defined otherwise herein. Should be interpreted openly. The steps of any method disclosed herein do not have to be performed in the exact order disclosed, unless explicitly stated.

本発明はここで、例として、添付の図面を参照して説明される。 The present invention will now be described, by way of example, with reference to the accompanying drawings.

ここで示された実施形態のための薬剤送達装置を図示する模式的な図である。3 is a schematic diagram illustrating a drug delivery device for the embodiments shown herein. FIG. ここで示された実施形態のための方法を図示するフローチャートである。6 is a flow chart illustrating a method for the embodiments shown herein. ここで示された実施形態のための薬剤送達装置を図示する模式的な図である。3 is a schematic diagram illustrating a drug delivery device for the embodiments shown herein. FIG.

詳細な説明
本発明は添付の図面を参照してより十分に説明され、そこで本発明の一定の実施形態が示される。この発明は、しかしながら、様々な異なる形態で具体化されてもよくここで説明された実施形態の限定されると解釈すべきではなく、むしろ、これらの実施形態はこの開示が全体的かつ網羅的で、当業者にこの発明の範囲を十分に伝達するよう例示の方法により提供される。 DETAILED DESCRIPTION The present invention will be more fully described with reference to the accompanying drawings, in which certain embodiments of the invention are shown. The present invention, however, should not be construed as limited to the embodiments set forth herein, which may be embodied in a variety of different forms, rather, these embodiments are not exhaustive of the overall and exhaustive disclosure of this disclosure. , By way of example, to fully convey the scope of the invention to those skilled in the art.

今日エンドユーザーが具体的な薬剤送達装置をどのように使用するかの追加的な情報を獲得可能な点に興味がある。一方で、新型薬剤送達装置たとえば多量注入の開発になるとこれは重要な情報である。他方で、技術は関連する訓練装置の完全な新型の世代の開始と、より良い遵守および固守のサポートにより現在の市場ニーズを満たすことができる。 Today we are interested in being able to obtain additional information on how end users will use a particular drug delivery device. On the other hand, this is important information when it comes to the development of new drug delivery devices such as high volume injections. On the other hand, the technology can meet the current market needs by launching a complete new generation of relevant training equipment and by supporting better compliance and adherence.

温度、動きのロギングおよび他のフィジカルパラメータを追跡する他の方法を含むスマートセンサが、今日利用可能である。この状況において、特に新型ＢＬＥ（Ｂｌｕｅｔｏｏｔｈ（登録商標）低エネルギー）／Ｂｌｕｅｔｏｏｔｈスマート技術の実装により、データロギングシステムは開発されてもよく、コインサイズのバッテリーで、非常に長時間持続する。 Smart sensors including temperature, motion logging and other methods of tracking other physical parameters are available today. In this situation, a data logging system may be developed, especially with the implementation of the new BLE (Bluetooth® low energy)/Bluetooth smart technology, which is a coin-sized battery and lasts a very long time.

薬剤送達装置の構成は機能性および注入を実行する使用者の行動に影響を及ぼす。薬剤送達装置の構成の修正が使用者の行動および薬剤送達装置の実行にいかに直接的な影響を及ぼすかを知ることは望ましい。 The configuration of the drug delivery device affects functionality and behavior of the user performing the infusion. It is desirable to know how modifying the configuration of a drug delivery device directly affects the behavior of the user and the performance of the drug delivery device.

そのようなデータの可視化および獲得は具体的な製品との組み合わせで顧客の行動のより深い評価のために有利であるかもしれない。 Visualization and acquisition of such data may be advantageous for a deeper assessment of customer behavior in combination with specific products.

リアルタイムの、高い正確性のロギングシステムはセンサ装置の使用によって提供されてもよく、センサ装置は１または複数の以下のセンサ：ジャイロスコープ、加速度計および／または磁力計を備える。リアルタイム可視化のためのセンサ装置を使用して、薬剤送達の外部のコンピュータ装置上にリアルタイム可視化を示す、ソフトウェアが提供されてもよい。薬剤送達装置外部のコンピュータ装置はディスプレイ装置を備える。そのようなコンピュータ装置の例はノート型ＰＣ、スマートモバイル装置、タブレットまたはこれに類するものなどでもよい。 A real-time, highly accurate logging system may be provided by the use of a sensor device, which sensor device comprises one or more of the following sensors: gyroscope, accelerometer and/or magnetometer. Using the sensor device for real-time visualization, software may be provided that shows the real-time visualization on a computer device external to drug delivery. The computer device external to the drug delivery device comprises a display device. Examples of such computing devices may be laptops, smart mobile devices, tablets or the like.

さらに、通信装置もまた、ロギング装置からのデータを薬剤送達装置の外部のコンピュータ装置に送信するように提供され、構成されてもよい。リアルタイムデータの送信は無線および／または有線で実行されてもよい。遠隔地への送信にもまた望ましい。通信装置は遠隔地へ送信する公知の技術を用いて、そのような送信を実行するために構成されるべきである。 Further, the communication device may also be provided and configured to send data from the logging device to a computing device external to the drug delivery device. The transmission of real-time data may be performed wirelessly and/or wired. Also desirable for transmission to remote locations. The communication device should be configured to perform such transmissions using known techniques for transmitting to remote locations.

後の分析のためにデータを保管することが望ましい場合もある。こうして、ロギングシステムから受信したデータが保管されてもよく保管されたデータが後に回収されてもよい記憶装置が提供されてもよい。記憶装置は不揮発性のメモリでもよい。 It may be desirable to archive the data for later analysis. Thus, a storage device may be provided in which the data received from the logging system may be archived and the archived data may be retrieved later. The storage device may be a non-volatile memory.

システムはただ動きの追跡を可能にするだけでなく、スマートセンサによって薬剤送達装置の起動状態に関する情報、またはさらなる情報さえも記録可能である。 Not only does the system allow tracking of movement, but smart sensors can also record information about the activation status of the drug delivery device, or even further information.

これは、たとえば自動注入ばねの電磁界の検知により起こり得る。この電磁界はたとえば配置されていたばねと配置されていないばねとで異なる。 This can occur, for example, by sensing the electromagnetic field of an automatic injection spring. This electromagnetic field is different, for example, between the arranged spring and the non-arranged spring.

直接のフィードバックにより、スマートフォンアプリケーションまたはソフトウェアなどのアプリケーションのシステム、および薬剤送達装置は使用者の操作行動を分析するために即時のフィードバックをもたらすツールになるかもしれない。 With direct feedback, application systems such as smartphone applications or software, and drug delivery devices may become tools that provide immediate feedback to analyze a user's operational behavior.

図１はここで示された実施形態のための薬剤送達装置を図示する模式的な図である。
薬剤送達装置１は、
薬剤送達装置１の動きを検知するよう構成されたセンサ装置２と、
薬剤装置１の使用者行動を追跡するよう構成されたロギング装置３を備え、使用者行動はセンサ装置２で検知された動きに基づく。 FIG. 1 is a schematic diagram illustrating a drug delivery device for the embodiments shown herein.
The drug delivery device 1 is
A sensor device 2 configured to detect movement of the drug delivery device 1;
A logging device 3 configured to track the user behavior of the medication device 1 is provided, the user behavior being based on movement detected by the sensor device 2.

薬剤送達装置１の動きにより、装置１全体の動きが示される。
センサ装置２は１またはそれ以上の以下のセンサ：磁力計、ジャイロスコープおよび／または加速度計を備える。磁力計は薬剤送達装置の自動注入針の位置を検知するために使用される。ジャイロスコープは薬剤送達装置１の位置を検知するために使用されてもよい。加速度計は動きの方向を検知するために使用されてもよい。ジャイロスコープおよび３つの加速度計を組み合わせて使用することにより、高い正確性の追跡が提供されてもよい。 Movement of the drug delivery device 1 indicates movement of the entire device 1.
The sensor device 2 comprises one or more of the following sensors: magnetometer, gyroscope and/or accelerometer. The magnetometer is used to detect the position of the autoinjection needle of the drug delivery device. The gyroscope may be used to detect the position of the drug delivery device 1. Accelerometers may be used to detect the direction of motion. The combined use of a gyroscope and three accelerometers may provide high accuracy tracking.

薬剤送達装置１は不揮発性メモリなどの記憶装置をさらに備えセンサ装置２からのデータおよび／またはロギング装置３からのデータを保管する。不揮発性メモリはたとえば読み込みのみのメモリ、フラッシュメモリ、強誘電体のＲＡＭ（ＦーＲＡＭ）、ほとんどの種類の磁気コンピュータ保管装置（たとえばハードディスク、フロッピディスク、および磁気テープ）、光学ディスクでもよい。不揮発性メモリは外部装置のリーダーに挿入されるよう、取外し可能でもよい。薬剤送達装置１は接触インターフェースを有していてもよく、保管されたデータはケーブル接続を通じて外部装置にアップロード可能である。さらに、薬剤送達装置１はリアルデータおよび／または保管されたデータを外部装置にアップロードするよう通信装置を有して提供されてもよい。通信装置はロギング装置からのリアルタイムデータを無線および、または有線で送信するか記憶装置からの保管されたデータを送信するよう構成される。通信装置はたとえばｗｉーｆｉ、ＢｌｏｏｔｏｏｔｈまたはＢＬＥを有していてもよい。 The drug delivery device 1 further includes a storage device such as a non-volatile memory, and stores the data from the sensor device 2 and/or the data from the logging device 3. Non-volatile memory may be, for example, read-only memory, flash memory, ferroelectric RAM (F-RAM), most types of magnetic computer storage devices (eg hard disks, floppy disks, and magnetic tapes), optical disks. The non-volatile memory may be removable for insertion into a reader on an external device. The drug delivery device 1 may have a contact interface and the stored data can be uploaded to an external device through a cable connection. Further, the drug delivery device 1 may be provided with a communication device to upload real data and/or stored data to an external device. The communication device is configured to wirelessly and/or wiredly transmit real-time data from the logging device or to transmit stored data from the storage device. The communication device may have, for example, wi-fi, Bluetooth or BLE.

ロギング装置３は薬剤送達装置１が輸送ボックスから取り外された際または保護キャップが薬剤送達装置から取り外された際に使用者行動の追跡を開始するよう構成されてもよい。使用者行動のデータは薬剤送達装置内の記憶装置たとえば不揮発性メモリ内に保管されるであろう。ユーザはこのケースにおいて起動の開始を覚えておく必要はなく、薬剤送達装置をいかにして外部装置に、有線または無線で接続するか理解しようと努める必要はない。すなわち使用者は従前の装置で行うことと何ら異なることをしなくてもよい。装置はたとえば製品をボックスから取り出して１週間以上の時間にわたって装置の使用および使用者の行動を自動的に記録してもよい。装置が輸送ボックスから取り外された際または保護キャップが薬剤送達装置から取り外された際に追跡を開始するために、装置内に非接続バッテリが含められてもよい。装置がボックスから取り外された際または保護キャップが薬剤送達装置から取り外された際、絶縁シートはバッテリと接触パッドとの間から取り外されてもよい。 The logging device 3 may be configured to start tracking user behavior when the drug delivery device 1 is removed from the shipping box or when the protective cap is removed from the drug delivery device. User behavior data may be stored in a storage device, such as non-volatile memory, within the drug delivery device. The user does not have to remember to start the activation in this case, nor does he have to try to figure out how to connect the drug delivery device to an external device, either wired or wireless. That is, the user does not have to do anything different from what he did with previous devices. The device may, for example, remove the product from the box and automatically record the use of the device and the behavior of the user over a week or more. An unconnected battery may be included in the device to begin tracking when the device is removed from the shipping box or when the protective cap is removed from the drug delivery device. The insulating sheet may be removed from between the battery and the contact pad when the device is removed from the box or when the protective cap is removed from the drug delivery device.

薬剤送達装置１は薬剤の送達のための実際の送達装置でもよい。使用者行動の追跡により、使用者が薬剤送達装置１を正しい方法で使用しているか否か後に認識することが可能である。外部装置にリアルタイムデータを送信することにより、直接フィードバックの可視化が提供されるかもしれない。 The drug delivery device 1 may be the actual delivery device for the delivery of drugs. By tracking the behavior of the user, it is possible to later recognize whether or not the user is using the drug delivery device 1 in the correct way. Direct feedback visualization may be provided by sending real-time data to an external device.

薬剤送達装置は人的要因研究または訓練のためのモックアップデモ装置でもよい。
薬剤送達装置はデータ保管とリアルタイムデータ送信の双方が提供されてもよい。たとえばＢｌｏｏｔｏｏｔｈを介してリアルタイムデータ検知のためにタブレットコンピュータに直接接続されることにより、リアルタイムの人的要因／患者研究が、患者が装置で何をするか／どのようにそれを取り扱うかを見るためになされ得る。データ保管により、将来のデータとの比較により、同一のデータは将来さらなる評価がもたらされてもよい。 The drug delivery device may be a mockup demo device for human factor studies or training.
The drug delivery device may be provided with both data storage and real-time data transmission. Connected directly to a tablet computer for real-time data detection, for example via Bluetooth, to allow real-time human factors/patient studies to see what the patient does/will handle on the device Can be done. Data retention may allow future comparisons of the same data by comparison with future data.

人的要因研究のために、修正されたパーツ（たとえば異なる起動ボタン、異なる装置表面など）を備え付けられた異なる装置を用いて患者の行動の追跡が可能となるよう、複数の装置が提供されてもよい。 For human factor studies, multiple devices are provided to allow tracking of patient behavior with different devices equipped with modified parts (eg different activation buttons, different device surfaces, etc.). Good.

訓練のために、患者は薬剤送達訓練装置を自宅で使用してもよい。患者が研究のオーガナイザーに装置を返還すると、オーガナイザーは患者が問題を抱えていたかどうかおよび患者が取扱いの指示に従っていたかどうかを理解して、たとえば患者とともにそのデータを評価することができるであろう。 For training, patients may use the drug delivery training device at home. When the patient returns the device to the study organizer, the organizer will be able to understand whether the patient had a problem and if the patient was following the handling instructions and could, for example, evaluate the data with the patient. ..

図２はここで示された実施形態の方法を図示するフローチャートである。
薬剤送達装置１の使用者行動の追跡のための方法は、
薬剤送達装置１の動きを検知するステップ１０と、
薬剤送達装置１の使用者の行動を検知された動きに基づいて追跡するステップ１１とを備える。 FIG. 2 is a flow chart illustrating the method of the embodiment shown herein.
The method for tracking the user behavior of the drug delivery device 1 is
Step 10 of detecting the movement of the drug delivery device 1 ,
Step 11 of tracking the behavior of the user of the drug delivery device 1 based on the detected movement.

図３はここで示された実施形態の薬剤送達システムを図示する模式的な図である。
薬剤送達システムは、
薬剤送達装置１とディスプレイ装置４を有する薬剤送達装置１の外部のコンピュータ装置とを備え、
薬剤送達装置は、
薬剤送達装置１の動きを検知するよう構成されたセンサ装置２と、
薬剤送達装置１の使用者行動を追跡するよう構成されたロギング装置３とを備え、使用者行動はセンサ装置２によって検知された動きに基づき、薬剤送達装置はさらに、
ロギング装置からのリアルタイムデータまたは記憶装置内に保管されたデータをロギング装置からディスプレイ装置４に無線または有線送信するよう構成された通信装置を備える。 FIG. 3 is a schematic diagram illustrating the drug delivery system of the embodiments shown herein.
Drug delivery system
A drug delivery device 1 and a computer device external to the drug delivery device 1 having a display device 4,
The drug delivery device is
A sensor device 2 configured to detect movement of the drug delivery device 1;
A logging device 3 configured to track user behavior of the drug delivery device 1, the user behavior being based on movement detected by the sensor device 2, the drug delivery device further comprising:
A communication device configured to wirelessly or wiredly transmit real-time data from the logging device or data stored in the storage device from the logging device to the display device 4.

本発明は主に少数の実施形態を参照して説明された。しかしながら、当業者には容易に理解できるように以上で説明されたもの以外の実施形態も、添付の特許請求の範囲で規定されたように、発明の範囲内で同等に可能である。 The invention has been mainly described with reference to a few embodiments. However, embodiments other than those described above, as would be readily apparent to a person skilled in the art, are equally possible within the scope of the invention, as defined by the appended claims.

Claims (5)

薬剤を患者の体内に注入するために用いられる薬剤送達装置（１）であって、
前記薬剤送達装置（１）の全体の動きを検知するよう構成されたセンサ装置（２）であって、前記薬剤送達装置に組み込まれたジャイロスコープおよび加速度計を含むセンサ装置（２）と、
前記センサ装置によって検知された、前記薬剤送達装置（１）の全体の動きのデータを記録するように構成されたロギング装置（３）と、
前記ロギング装置（３）からの、記録された前記データを保管するように構成された記憶装置と、
前記記憶装置に保管された前記データまたは前記ロギング装置に記録された前記データを、前記薬剤送達装置（１）によって薬剤を投与する使用者の行動の評価のため、前記薬剤送達装置（１）の外部のコンピュータ装置に送信するよう構成された通信装置とを備え、
前記薬剤送達装置（１）はさらに、バッテリーと、コンタクトパッドと、前記バッテリーと前記コンタクトパッドとの間に位置する絶縁シートとを備え、前記絶縁シートは前記薬剤送達装置から取り外されるように構成され、
前記ロギング装置（３）は前記薬剤送達装置（１）が、前記薬剤装置の輸送に用いられる輸送ボックスから取り外されたときまたは前記薬剤保護装置を保護する保護キャップが前記薬剤送達装置から取り外されたときに、前記絶縁シートが除去されることによって、前記バッテリーが前記薬剤送達装置に電気的に接続されることにより、前記センサ装置（２）によって検知される前記薬剤送達装置全体の動きの前記データの記録を開始するよう構成された、薬剤送達装置（１）。 Drug drug delivery device (1) used in order to inject into the patient met with,
Sensor device comprising a sensor device configured to sense a motion of the entire (2), gyroscopes and accelerometers incorporated into the drug delivery device prior Symbol medicament delivery device (1) and (2),
A logging device (3) configured to record data of overall movement of the drug delivery device (1) as sensed by the sensor device;
A storage device in which the logging device (3), configured to store the recorded the data,
The data recorded in the data or the logging device stored in the storage device, for the evaluation of actions of the user to administer the drug by the drug delivery device (1), the drug delivery device of (1) Bei example an external communication apparatus configured to transmit to the computer device,
The drug delivery device (1) further comprises a battery, a contact pad, and an insulating sheet located between the battery and the contact pad, the insulating sheet being configured to be removed from the drug delivery device. ,
The logging device (3) has a protective cap removed from the drug delivery device when the drug delivery device (1) is removed from a shipping box used to transport the drug device or the drug protection device is protected. Occasionally, the insulation sheet is removed to electrically connect the battery to the drug delivery device, thereby sensing the movement of the entire drug delivery device as sensed by the sensor device (2). A drug delivery device (1) configured to initiate recording of . 前記記憶装置は不揮発性のメモリである、請求項１に記載の薬剤送達装置（１）。 The drug delivery device (1) according to claim 1, wherein the storage device is a non-volatile memory. 前記通信装置は前記記憶装置からの保管されたデータを無線または有線送信するよう構成された、請求項１に記載の薬剤送達装置（１）。 The drug delivery device (1) according to claim 1, wherein the communication device is configured to wirelessly or wiredly transmit the stored data from the storage device. 前記薬剤送達装置（１）は薬剤の注入のための実際の送達装置（１）である、請求項１から３のいずれか１項に記載の薬剤送達装置（１）。 The drug delivery device (1) according to any one of claims 1 to 3 , wherein the drug delivery device (1) is an actual delivery device (1) for injection of a drug. 薬剤送達システムであって、
薬剤を患者の体内に注入するために用いられる薬剤送達装置（１）を備え、
前記薬剤送達システムはさらに、
ディスプレイ装置（４）を有する前記薬剤送達装置（１）の外部のコンピュータ装置とを備え、
前記薬剤送達装置は、
前記薬剤送達装置（１）の全体の動きを検知するよう構成されたセンサ装置（２）であって、前記薬剤送達装置に組み込まれたジャイロスコープおよび加速度計を含むセンサ装置（２）と、
前記センサ装置によって検知された、前記薬剤送達装置（１）の全体の動きのデータを記録するように構成されたロギング装置（３）と、
前記ロギング装置からの、記録された前記データを記憶するように構成された記憶装置と、
保管された前記データまたは前記ロギング装置に記録された前記データを、使用者の行動の評価のため、前記コンピュータ装置に送信するよう構成された通信装置とを備え、
前記薬剤送達装置（１）はさらに、バッテリーと、コンタクトパッドと、前記バッテリーと前記コンタクトパッドとの間に位置する絶縁シートとを備え、前記絶縁シートは前記薬剤送達装置から取り外されるように構成され、
前記ロギング装置（３）は前記薬剤送達装置（１）が、前記薬剤装置の輸送に用いられる輸送ボックスから取り外されたときまたは前記薬剤保護装置を保護する保護キャップが前記薬剤送達装置から取り外されたときに、前記絶縁シートが除去されることによって、前記バッテリーが前記薬剤送達装置に電気的に接続されることにより、前記センサ装置（２）によって検知される前記薬剤送達装置全体の動きの前記データの記録を開始するよう構成された、薬剤送達システム。 A drug delivery system,
Drug delivery device used drugs in order to inject into a patient comprising a (1),
Before Symbol drug delivery system further,
A computer device external to the drug delivery device (1) having a display device (4),
The drug delivery device comprises
A sensor device (2) configured to detect overall movement of the drug delivery device (1), the sensor device (2) including a gyroscope and an accelerometer integrated into the drug delivery device ;
A logging device (3) configured to record data of overall movement of the drug delivery device (1) as sensed by the sensor device;
A storage device wherein from the logging device, configured to store the recorded the data,
The data recorded in the data or the logging device is holding tube, for the assessment of behavior in use for business, Bei example a communication apparatus configured to transmit to said computer device,
The drug delivery device (1) further comprises a battery, a contact pad, and an insulating sheet located between the battery and the contact pad, the insulating sheet being configured to be removed from the drug delivery device. ,
The logging device (3) has a protective cap for protecting the drug protection device removed from the drug delivery device when the drug delivery device (1) is removed from a shipping box used to transport the drug device. Sometimes, the insulating sheet is removed to electrically connect the battery to the drug delivery device, thereby detecting the movement of the entire drug delivery device detected by the sensor device (2). A drug delivery system configured to initiate recording of .
JP2017509755A 2014-08-19 2015-08-03 Drug delivery device and system with motion detector for recording and tracking user activity Active JP6751386B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1450959 2014-08-19
SE1450959-0 2014-08-19
PCT/EP2015/067799 WO2016026679A1 (en) 2014-08-19 2015-08-03 Medicament injection device or injection mock-up demo device with motion detector to log and track user behaviour

Publications (2)

Publication Number Publication Date
JP2017525473A JP2017525473A (en) 2017-09-07
JP6751386B2 true JP6751386B2 (en) 2020-09-02

Family

ID=53785631

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017509755A Active JP6751386B2 (en) 2014-08-19 2015-08-03 Drug delivery device and system with motion detector for recording and tracking user activity

Country Status (7)

Country Link
US (4) US10593232B2 (en)
EP (1) EP3183017A1 (en)
JP (1) JP6751386B2 (en)
KR (1) KR20170035969A (en)
CN (1) CN106575319B (en)
TW (1) TWI569833B (en)
WO (1) WO2016026679A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11627944B2 (en) 2004-11-30 2023-04-18 The Regents Of The University Of California Ultrasound case builder system and method
DK2689359T3 (en) 2011-03-24 2021-02-08 Sanofi Aventis Deutschland APPARATUS AND METHOD FOR DETECTING AN ACTIVATION ACTION THAT CAN BE PERFORMED WITH A MEDICAL DEVICE
US11631342B1 (en) 2012-05-25 2023-04-18 The Regents Of University Of California Embedded motion sensing technology for integration within commercial ultrasound probes
DK2988807T3 (en) 2013-04-22 2018-09-03 Sanofi Aventis Deutschland OLED SENSOR DEVICE
US10380919B2 (en) 2013-11-21 2019-08-13 SonoSim, Inc. System and method for extended spectrum ultrasound training using animate and inanimate training objects
EP3058970A1 (en) 2015-02-19 2016-08-24 Sanofi-Aventis Deutschland GmbH Data collection device for attachment to an injection device
EP3067081A1 (en) 2015-03-12 2016-09-14 Sanofi Drug delivery device
ES2805230T5 (en) 2015-06-09 2023-11-24 Sanofi Aventis Deutschland Data collection apparatus for attachment to an injection device
US11600201B1 (en) 2015-06-30 2023-03-07 The Regents Of The University Of California System and method for converting handheld diagnostic ultrasound systems into ultrasound training systems
EP3407940A4 (en) 2016-01-29 2019-09-04 Companion Medical, Inc. Automatic medication delivery tracking
DE102016104101A1 (en) * 2016-03-07 2017-09-07 Emperra Gmbh E-Health Technologies Injection device for injecting metered quantities of a liquid therapeutic agent
WO2017201185A1 (en) * 2016-05-19 2017-11-23 Becton, Dickinson And Company Diagnostic measurement apparatus
DK3488365T3 (en) * 2016-07-22 2023-06-26 Shl Medical Ag DEVICE AND SYSTEM FOR OBTAINING MEDICINE-RELATED INFORMATION
US10896628B2 (en) 2017-01-26 2021-01-19 SonoSim, Inc. System and method for multisensory psychomotor skill training
US11083852B2 (en) 2017-12-12 2021-08-10 Bigfoot Biomedical, Inc. Insulin injection assistance systems, methods, and devices
US11116899B2 (en) 2017-12-12 2021-09-14 Bigfoot Biomedical, Inc. User interface for diabetes management systems and devices
US11464459B2 (en) 2017-12-12 2022-10-11 Bigfoot Biomedical, Inc. User interface for diabetes management systems including flash glucose monitor
US11077243B2 (en) 2017-12-12 2021-08-03 Bigfoot Biomedical, Inc. Devices, systems, and methods for estimating active medication from injections
US10987464B2 (en) 2017-12-12 2021-04-27 Bigfoot Biomedical, Inc. Pen cap for insulin injection pens and associated methods and systems
US11090439B2 (en) 2017-12-12 2021-08-17 Bigfoot Biomedical, Inc. Therapy management systems, methods, and devices
CN111712285B (en) * 2017-12-21 2022-08-12 赛诺菲 Determining injection status
US11810473B2 (en) 2019-01-29 2023-11-07 The Regents Of The University Of California Optical surface tracking for medical simulation
US11495142B2 (en) 2019-01-30 2022-11-08 The Regents Of The University Of California Ultrasound trainer with internal optical tracking
WO2020182403A1 (en) * 2019-03-13 2020-09-17 Shl Medical Ag Medicament delivery device development evaluation system
US11948671B2 (en) 2019-04-11 2024-04-02 Medtronic Minimed, Inc. Intelligent accessories for medicine dispensing device
US20230260426A1 (en) * 2020-06-25 2023-08-17 Sanofi A Training Device, System and Method
CN112071149A (en) * 2020-09-17 2020-12-11 苏州智昕医教科技有限公司 Wearable medical simulation puncture skill training system and method
CN115429978B (en) * 2022-09-21 2023-06-30 苏州芙迈蕾医疗科技有限公司 Intelligent electronic injector control boosting device

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2262291Y (en) 1996-01-25 1997-09-10 蔡辉阳 Automatic voice controller
US20040073175A1 (en) * 2002-01-07 2004-04-15 Jacobson James D. Infusion system
CN1966100A (en) * 2006-07-05 2007-05-23 南宁松景天伦生物科技有限公司 Medicinal multifunctional intelligentized transfusion monitoring system based on wireless digital transmission
EP2023256A1 (en) * 2007-08-02 2009-02-11 Novo Nordisk A/S Drug administration monitoring
CN201350284Y (en) * 2009-01-05 2009-11-25 深圳圣诺医疗设备有限公司 High pressure injector for monitoring injection pressure in real time
CN107412916A (en) * 2009-02-27 2017-12-01 生命扫描有限公司 Delivery system
US20110049060A1 (en) * 2009-08-25 2011-03-03 Dindo Uy Indicators principally for use in connection with water-treatment materials for pools and spas
US8096186B2 (en) * 2010-03-24 2012-01-17 Carefusion 303, Inc. Systems and methods for measuring fluid pressure within a disposable IV set connected to a fluid supply pump
WO2012152628A1 (en) * 2011-05-06 2012-11-15 Novo Nordisk A/S System for optimizing a drug dosage regimen over time
US20120330571A1 (en) * 2011-06-27 2012-12-27 Lacourse John R System to measure forces on an insertion device
CA2838986A1 (en) * 2011-06-28 2013-01-03 Alk Ag A method, a device and a computer program product for training the use of an auto-injector
CN202182795U (en) * 2011-07-26 2012-04-04 北京鑫禾丰医疗技术有限公司 Jam detection device
US8755743B2 (en) * 2011-07-29 2014-06-17 Bose Corporation Earpiece messaging
EP3736004A1 (en) * 2012-02-13 2020-11-11 Sanofi-Aventis Deutschland GmbH Monitoring device for monitoring operation of a drug delivery device
MX347426B (en) * 2012-03-02 2017-04-26 Abbvie Inc Automatic injection training device.
KR101945341B1 (en) * 2012-04-17 2019-02-08 삼성전자주식회사 Apparatus and method for auto-supplying insulin according to exercise
WO2014004437A1 (en) * 2012-06-25 2014-01-03 Gecko Health Innovations, Inc. Devices, systems, and methods for adherence monitoring and patient interaction
JP6385927B2 (en) * 2012-08-03 2018-09-05 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Supplementary device for attachment to an injection device
US20140324463A1 (en) * 2013-04-26 2014-10-30 Roche Diagnostics Operations, Inc. Web account creation and management, data sharing, home page setting, and data reporting

Also Published As

Publication number Publication date
CN106575319B (en) 2021-08-10
TW201620560A (en) 2016-06-16
US20210217327A1 (en) 2021-07-15
US20200312191A1 (en) 2020-10-01
EP3183017A1 (en) 2017-06-28
KR20170035969A (en) 2017-03-31
US10593232B2 (en) 2020-03-17
TWI569833B (en) 2017-02-11
US20200152087A1 (en) 2020-05-14
US10733909B2 (en) 2020-08-04
CN106575319A (en) 2017-04-19
JP2017525473A (en) 2017-09-07
US11386809B2 (en) 2022-07-12
US20170270829A1 (en) 2017-09-21
WO2016026679A1 (en) 2016-02-25
US11037468B2 (en) 2021-06-15

Similar Documents

Publication Publication Date Title
JP6751386B2 (en) Drug delivery device and system with motion detector for recording and tracking user activity
US9700674B2 (en) Injection device configured to mate with a mobile device
CN106068510B (en) System and method for ensuring patient medication and fluid delivery at a clinical point of use
CN107530224A (en) Use Sensor monitoring pharmaceutical admixtures compliance
JP7170697B2 (en) Systems and methods for ensuring patient medication and fluid delivery in clinical use
US20140193788A1 (en) Method, a device and a computer program product for training the use of an auto-injector
JP2015534661A5 (en)
US11504009B2 (en) System and method for dose capture with flow patch and delivery infomatics
US11517506B2 (en) System and method for tracking and regulating removal of patient medications
US11482315B2 (en) Device accessory for digitally monitoring autoinjector usage for improved compliance, remote patient monitoring, and adherence
JP7427111B2 (en) Activation and detection system for auxiliary devices attached to drug delivery devices
JP6444478B2 (en) Analysis method of measurement technique in biological information measuring instrument

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170414

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170414

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180228

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180306

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180605

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180705

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180918

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190117

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20190125

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20190222

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20190419

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200428

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200603

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20200814

R150 Certificate of patent or registration of utility model

Ref document number: 6751386

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250